Q1 2012 · —
Revenue$34.00K$34.00K no prior Q1 2011 on file
Net income—
EPS Diluted-$2.71-$2.71 no prior Q1 2011 on file
Operating Income-$3,983,000—
Margins · derived
Operating margin-11714.7%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q1 2011 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Karyopharm Therapeutics Inc. · CIK 1503802 · Engraved from SEC EDGAR